Faris Tamimi

16PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsMidwifery not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 15, 2026
On-Treatment NLR Dynamics During CDK4/6 Inhibition Are Associated with Overall Survival in Metastatic Breast Cancer.

|May 29, 2026
Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

|Apr 15, 2026
Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer.

Baha Sharaf, Alaa Seif, Hira Bani Hani

|Sep 05, 2025
Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid Biopsy.

Rashid Abdel-Razeq, Asem Mansour, Maha Barbar

|Mar 18, 2025
Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer.

Tamer Al-Batsh, Nayef Abdel-Razeq, Yosra Al-Masri

|Mar 11, 2025
Dual Anti-HER2 Therapy Vs Trastuzumab Alone with Neoadjuvant Anthracycline and Taxane in HER2-Positive Early-Stage Breast Cancer: Real-World Insights.

Baha Sharaf, Faris Tamimi, Haneen Al-Abdallat

Pageof 3

Frequent Collaborators

10 joint publications

Hikmat Abdel-Razeq

9 joint publications

Baha' Sharaf

2 joint publications

Mahmoud Abunasser

2 joint publications

Sarah Edaily